Read the following argument carefully:
In an effort to reduce drug development costs, several biotechnology firms have proposed replacing traditional human clinical trials with advanced artificial intelligence predictive modeling. Many health policy analysts argue that this substitution will inevitably compromise patient safety because AI algorithms cannot account for rare biological interactions. However, this concern is largely misplaced. AI models are designed to synthesize vast genomic datasets that human researchers cannot process, identifying dangerous interactions far earlier in the development pipeline. Consequently, adopting predictive modeling will ultimately enhance, rather than diminish, drug safety protocols.
True or False statement: In the argument above, the first boldfaced statement provides evidence supporting the main position defended by the author, while the second boldfaced statement expresses that main position.
Cevap: Cevap